152 results
Page 3 of 8
8-K
EX-99.1
k4vvmyld9 e7
26 Apr 23
Regulation FD Disclosure
5:00pm
PRE 14A
hwa17nbsa4jq kdzkna
18 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.2
xcr hg34ugdp7x
17 Apr 23
Zentalis announces preclinical data supporting Cyclin E1 as a predictive marker for azenosertib treatment at AACR Annual Meeting 2023
9:07am
8-K
EX-99.1
sfqd 6rkthzb
17 Apr 23
Zentalis announces preclinical data supporting Cyclin E1 as a predictive marker for azenosertib treatment at AACR Annual Meeting 2023
9:07am
8-K
EX-99.1
7y13atisi6afx
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
8-K
EX-99.2
jad j0drp
9 Nov 22
Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates
7:04am
10-K/A
2219s7s1wh3t0usj
31 Oct 22
Annual report (amended)
5:24pm
8-K
EX-99.2
tkvx h3sj561s7ak
9 Aug 22
Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
12:00am
8-K
EX-10.3
mcxhg
22 Jul 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.2
5bu5ghimp9k5 wh
22 Jul 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
xh7o87 s3g6yr3u50
22 Jul 22
Departure of Directors or Certain Officers
4:15pm
DEFA14A
ly7ms
31 May 22
Additional proxy soliciting materials
4:03pm
8-K
EX-10.1
hmpnmzat3clc8a0ukl
31 May 22
Departure of Directors or Certain Officers
4:03pm